Humulin L

Roman name

Humulin-L

The composition and the form of

1 ml insulin-zink suspension for injection of human insulin in 1940, or 100 U; in vials of 10 ml.

Characteristics

Patient median duration.

Of drugs

Gipoglikemicescoe. Increases the absorption of glucose tissues. Prevents break glycogen in the liver and stimulate its education.

Clinical pharmacology

Effect develops through 30 minutes, reaching a maximum at 16 h after the introduction, and continues 24 hours

Indications

Insulinzawisimy diabetes, insulinnezawisimy diabetes.

Contraindications

Hypoglycaemia.

Side-Effects

Hypoglycaemia, lipodistrofia, allergic reactions.

Patient interaction

Gipoglikemiceski effect reinforce MAO inhibitors, alcohol, selective beta-adrenoblokatora, sulfanilamida; Lower-oral contraceptives, glukokortikoida, tireoidnye hormones, tiazidnye dioretiki.

Precautions

The transfer of patients from insulinov animal origin for human can be reduced dosage and / or modification factor is the ratio of products varying duration. Dose reduced immediately or gradually (over several weeks). Risk gipoglikemii development in the transition from one type of insulin to another is not significant if daily intake drug less than 40 U.

Dosing and Administration

P / to the in / m; The injections be changed. Dose is a case-by-case basis. When alone introduces 1-2 times a day. The possible combination with Humulinom Regular.

Storage conditions

susp.d / in. : List B. In the refrigerator at a temperature of 2-8 ° C (not freezing)

Shelf life

susp.d / in. : 1.5 g.

Directory → Hormones and their antagonists → Insulins → Humulin L